Trial Profile
A phase I trial of LX 4211 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2011
Price :
$35
*
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 15 Sep 2009 Status changed from recruiting to completed; reported by Lexicon in a media release.
- 11 Dec 2008 New trial record.
- 01 Dec 2008 Investigational New Drug Application submitted.